Sanara MedTech (SMTI) PT Lowered to $40 at Cantor Fitzgerald, Overweight Rating Maintained
Tweet Send to a Friend
Cantor Fitzgerald analyst Ross Osborn lowered the price target on Sanara MedTech (NASDAQ: SMTI) to $40.00 (from $45.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
